Development and validation of the PAIR (Pharmacotherapy Assessment in Chronic Renal Disease) criteria to assess medication safety and use issues in patients with CKD.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American Journal of Kidney Diseases

• Publication date

  2011-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/j.ajkd.2011.04.020PMID 21778005
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Introduction.

  2013cited by this paper
• The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

  2010cited by this paper
• The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapy

  2009cited by this paper
• KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

  2009cited by this paper
• Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease- Mineral and Bone Disorder (CKD-MBD)

  2009cited by this paper
• Canadian Cardiovascular Society / Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations

  2009cited by this paper
• Sensitivity of Patient Outcomes to Pharmacist Interventions. Part III: Systematic Review and Meta-Analysis in Hyperlipidemia Management

  2008cited by this paper
• Prevalence of chronic kidney disease in population-based studies: Systematic review

  2008cited by this paper
• STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation.

  2008cited by this paper
• Evaluation of a training and communication-network nephrology program for community pharmacists

  2008cited by this paper
• Development of quality indicators for the antibiotic treatment of complicated urinary tract infections: a first step to measure and improve care.

  2008cited by this paper
• Appropriate prescribing in elderly people: how well can it be measured and optimised?

  2007cited by this paper
• Sensitivity of Patient Outcomes to Pharmacist Interventions. Part I: Systematic Review and Meta-Analysis in Diabetes Management

  2007cited by this paper
• KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target.

  2007cited by this paper
• KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.

  2007cited by this paper
• Hypertenion: Sensitivity of Patient Outcomes to Pharmacist Interventions. Part II: Systematic Review and Meta-Analysis in Hypertension Management

  2007cited by this paper
• KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target.

  2007cited by this paper
• Appropriateness of colorectal cancer screening: appraisal of evidence by experts.

  2006cited by this paper
• KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease.

  2006cited by this paper
• Measuring health: A guide to rating scales and questionnaires, 3rd ed.

  2006cited by this paper
• Natural medicines : comprehensive database

  2006cited by this paper
• Medication-related problems in ambulatory hemodialysis patients: a pooled analysis.

  2005cited by this paper
• K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.

  2004cited by this paper
• K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease

  2004cited by this paper
• K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease.

  2003cited by this paper
• Medication-related problem type and appearance rate in ambulatory hemodialysis patients

  2003cited by this paper
• Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.

  2003cited by this paper
• Examination of Resource Use and Clinical Interventions Associated With Chronic Kidney Disease in a Managed Care Population

  2003cited by this paper
• Reliability of a modified medication appropriateness index in community pharmacies.

  2003cited by this paper
• K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

  2003cited by this paper
• Nephrology: 3. Safe drug prescribing for patients with renal insufficiency.

  2002cited by this paper
• K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

  2002cited by this paper
• Assessing Care of Vulnerable Elders: ACOVE Project Overview

  2001cited by this paper
• The RAND/UCLA Appropriateness Method User's Manual

  2001cited by this paper
• Development, implementation and reliability assessment of an emergency physician performance evaluation tool.

  2000cited by this paper
• Development and validation of an improving prescribing in the elderly tool.

  2000cited by this paper
• Defining inappropriate practices in prescribing for elderly people: a national consensus panel.

  1997cited by this paper
• A method for assessing drug therapy appropriateness.

  1992cited by this paper
• Drug-Related Problems: Their Structure and Function

  1990cited by this paper
• A Method for the Detailed Assessment of the Appropriateness of Medical Technologies

  1986cited by this paper
• Drug prescribing in renal failure: dosing guidelines for adults.

  1983cited by this paper
• Drug Prescribing in Renal Failure

  1979cited by this paper
• The measurement of observer agreement for categorical data.

  1977cited by this paper

• A Systematic Review of Potential Opioid Prescribing Safety Indicators

  2025cites this paper
• Improving medication safety and prescribing of higher-risk medications in individuals with chronic kidney disease: A validation study

  2025cites this paper
• Deprescribing tools and guidelines in chronic kidney disease: A scoping review.

  2025cites this paper
• Determination of drug-related problems according to PAIR criteria in dialysis patients: a cross-sectional study in tertiary care hospital

  2024influential citation
• Medications for community pharmacists to dose adjust or avoid to enhance prescribing safety in individuals with advanced chronic kidney disease: a scoping review and modified Delphi

  2024cites this paper
• Drug Related Problems in Chronic Kidney Disease: A Brief Review

  2021cites this paper
• Response to the article “Pharmacotherapy assessment in chronic kidney disease: validation of the pair instrument for use in Brazil”

  2020cites this paper
• [Cross-cultural adaptation of the PAIR instrument: Pharmacotherapy Assessment in Chronic Renal Disease for application in Brazil].

  2020cites this paper
• Pharmacotherapy assessment in chronic kidney disease: validation of the PAIR instrument for use in Brazil

  2020cites this paper
• Adaptação transcultural e validação do instrumento PAIR - Pharmacotherapy Assessment in Chronic Renal Disease –para aplicação em renais crônicos no Brasil

  2019influential citation
• VARIABLES IMPACTING GFR ESTIMATION METHOD FOR DRUG DOSING IN CKD: ARTIFICIAL NEURAL NETWORK PREDICTION MODEL

  2019cites this paper
• Identifying potential prescribing safety indicators related to mental health disorders and medications: A systematic review

  2019cites this paper
• Development and validation of PART (Pharmacotherapy Assessment in Renal Transplant Patients) criteria to assess drug‐related problems in an outpatient renal transplant population: A cross‐sectional study

  2019cites this paper
• Beliefs influencing community pharmacists' interventions with chronic kidney disease patients: A theory‐based qualitative study

  2019cites this paper
• Concordance Among Methods for Empiric Renal Drug Dosing: Meropenem as a Role Model for Clinical Superiority of Cockroft–Gault or Modification of Diet in Renal Disease:

  2018cites this paper
• Prevalence and Management of Drug-Related Problems in Chronic Kidney Disease Patients by Severity Level: A Subanalysis of a Cluster Randomized Controlled Trial in Community Pharmacies

  2018influential citation
• Évaluation de la sévérité des problèmes liés à la pharmacothérapie chez les patients souffrant d’insuffisance rénale chronique : la perspective de la pharmacie communautaire

  2018influential citation
• Quality of prescribing in chronic kidney disease and type 2 diabetes

  2018cites this paper
• Effects of Higher Quality of Care on Initiation of Long-term Dialysis in Patients With CKD and Diabetes.

  2017cites this paper
• Investigating the Relative Significance of Drug-Related Problem Categories

  2017cites this paper
• Community Pharmacist Training-and-Communication Network and Drug-Related Problems in Patients With CKD: A Multicenter, Cluster-Randomized, Controlled Trial.

  2017cites this paper
• Altered Pharmacology and Pill Burden in Older Adults: A Balancing Act

  2016cites this paper
• Validation of tools for the evaluation of pharmaceutical services: A systematic review

  2016cites this paper
• Development and initial validation of prescribing quality indicators for patients with chronic kidney disease.

  2016influential citation
• Process quality indicators for chronic kidney disease risk management: a systematic literature review

  2016influential citation
• Continuous quality improvement in nephrology: a systematic review

  2016cites this paper
• Evaluation of the potential impact of pharmacist interventions : development and validation of the CLEO multidimensional tool

  2015cites this paper
• Development and validation of criteria for classifying severity of drug-related problems in chronic kidney disease: A community pharmacy perspective.

  2015cites this paper
• Improving Care of Patients With CKD: The 2015 National Kidney Foundation Presidential Address.

  2015cites this paper
• [Drug treatment of inpatients with chronic kidney disease in the acute care ward of a Swiss regional hospital].

  2015cites this paper
• Defining risk factors associated with renal and cognitive dysfunction

  2014cites this paper
• Impact of the Pharmacist Medication Review Services on Drug-Related Problems and Potentially Inappropriate Prescribing of Renally Cleared Medications in Residents of Aged Care Facilities

  2014cites this paper
• Development of a conceptual framework for medication safety measurement

  2014cites this paper
• [Not Available].

  2014cites this paper
• Should residency projects involve more than one resident?

  2014cites this paper
• Renal function estimation : the implications for clinical practice

  2014cites this paper
• New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication management

  2013cites this paper
• Optimising drug prescribing and dispensing in subjects at risk for drug errors due to renal impairment: improving drug safety in primary healthcare by low eGFR alerts

  2013cites this paper
• Connaissances et compétences des pharmaciens communautaires et qualité de la pharmacothérapie des patients atteints d’insuffisance rénale chronique : Résultats provisoires du programme ProFiL

  2013cites this paper
• Evaluation of the impact of pharmaceutical care service on hospitalized patients with chronic kidney disease in Jordan

  2013cites this paper
• Standards of clinical practice for renal pharmacists.

  2013cites this paper
• For peer review only Optimizing drug prescribing and dispensing in subjects at risk for drug errors due to renal impairment: a survey on improving drug safety in primary health care by low eGFR alerts.

  2012cites this paper
• Pharmacist Web‐Based Training Program on Medication Use in Chronic Kidney Disease Patients: Impact on Knowledge, Skills, and Satisfaction

  2011cites this paper